Using a Bilingual App and Patient Navigation to Improve Hormone Therapy Adherence in Latina Breast Cancer Patients with Social Barriers

What this Trial Is About

Researchers are evaluating the effectiveness of a bilingual, culturally tailored mobile app called the HT Helper App combined with patient navigation support to improve adherence to hormone therapy among Latina breast cancer patients. These patients face non-medical barriers such as income, health insurance, education, health literacy, and language difficulties that impact their medication adherence. The study aims to reduce breast cancer recurrence and mortality by promoting better treatment adherence and self-care skills. The study compares three groups one using the HT Helper App plus patient navigation, one receiving patient navigation alone, and one receiving usual care. It is a 4-year randomized controlled trial enrolling 159 Latina patients diagnosed with hormone receptor-positive breast cancer who have started hormone therapy within the past 1 to 24 months. The intervention is based on Social Cognitive Theory and Motivational Interviewing. Assessments are done at baseline, 3, 6, 12, and 18 months. Participants will be involved in completing questionnaires and using the app or navigation services depending on their group. Researchers will measure hormone therapy adherence, patient self-efficacy in managing side effects and medication use, social support, quality of life, depression, and anxiety throughout the 18 months. The trial aims to produce a scalable intervention that addresses social barriers and improves equitable breast cancer outcomes for underserved Latina patients.

mHealth to Improve Medication Adherence Among Latina Breast Cancer Patients Experiencing Non-Medical Drivers of Health